Dr. Abdelilah Arredouani

Abdelilah Arredouani

 Tel: +974 4454 2947
Dr. Abdelilah Arredouani joined QBRI in March 2012 as a Scientist and he is a member of the Diabetes Research Center. Dr. Arredouani holds a Special diploma in Molecular Biology and Biotechnology Management and a Ph.D. from Belgium and prior to joining QBRI he worked in Netherlands, United Kingdom and Qatar. During his Ph.D., he studied the role of the endoplasmic reticulum calcium stores in glucose-induced calcium response and insulin secretion from the pancreatic beta cell in the context of type 2 diabetes. He started his postdoctoral training in the Department of Neurosciences at Erasmus Medical Center in the Netherlands and moved to Oxford University in the United Kingdom to work in the Department of Pharmacology where he investigated the role of the calcium mobilizing messenger NAADP in glucose-induced calcium response and insulin secretion in pancreatic beta cell. He was a key player in the discovery of the NAADP receptor (two pore channels or TPC) and Ned-19, a specific antagonist of the NAADP. While at Weill Cornell medical college in Qatar, Dr. Arredouani worked on the trafficking of ORAI1, a calcium channel involved in store-operated calcium entry.
Dr. Arredouani’s current research focuses on the understanding of the pathophysiology of type 2 diabetes. He is involved in different projects including the understanding of the mechanisms that underlie the remission of type 2 diabetes after bariatric surgery, the identification of biomarkers to predict future development of type 2 diabetes, the association of the copy number variation of the salivary alpha amylase with obesity and type 2 diabetes, as well as the role of heat shock proteins in the development of obesity and diabetes. Dr. Arredouani is an expert in calcium signaling and cellular physiology and combines molecular and cellular techniques with systems biology approaches, mainly metabolomics, in his investigations.
  1. Understanding the association of copy number variation at the salivary alpha-amylase gene with risk of obesity
  2. Identification of predictive biomarkers for type 2 diabetes using metabolomics
  3. In vivo and in vitro role of DNAJB3/HSP-40 co-chaperone in controlling glucose homeostasis and insulin signaling in the context of type diabetes and obesity
Collaborator Name Institute Research Area
Dr. Mario Falchi Kings College London, UK In this project we use metabolomics to try understand how the low copy number of the salivary alpha amylase gene AMY1 associates with the risk of obesity
Prof. Philippe Froguel Lille University, France This project aims at identifying biomarkers to predict T2D. Predictive biomarkers for T2D are essential for the implementation of strategies to prevent the disease or at least delay its onset.
Dr. Mohamed Dehbi Qatar Biomedical Research institute Type 2 diabetes and insulin resistance. Cell and molecular biology techniques are used in this project to try understanding the role of DNAJB3 in insulin resistance and T2D.
Dr. Mohamed Chikri Qatar Biomedical Research institute MicroRNAs and insulin resistance
Dr. Shehab Khan Hamad Medical Corporation This study looks at the effect of a plant extract on the proliferation of colorectal cancer cells.
Dr. Fouad Azizi Hamad Medical Corporation This study focuses on the effect of a calcium channel blocker on the proliferation of Leukemia cancer cells.
Institution Course Name Role
Oxford University, UK cell physiology, cell signaling Tutor
Oxford University, UK metabolism and endocrinology Lectures and Seminars
Qatar University Bioethics and pathophysiology courses Lecturor
Name Institution Period
Lab. Technicians various - Belgium, Netherlands, UK and Qatar 2005 - 2010
Undergraduate Students Oxford University, UK 2005 - 2010
Masters Students Oxford University, UK 2007 - 2010
Ph.D. Students Oxford University, UK 2004 - 2010
Lab. Technicians & SRP students QBRI 2015 onwards
Back to Top